Fixation method influences FLASH skin sparing in an in vivo leg model
- PMID: 40762144
- PMCID: PMC12340987
- DOI: 10.2340/1651-226X.2025.43972
Fixation method influences FLASH skin sparing in an in vivo leg model
Abstract
Background and purpose: The FLASH effect, where ultra-high dose rate elicits a favourable normal tissue-sparing, has been shown in several preclinical studies. Study setup differences, for example fixation methods that affect blood flow, can influence radiation response but are unexplored for FLASH. This study compared FLASH's acute skin-sparing effect with two fixation methods: a glued fixation (no blood flow restriction) and taped fixation (slight blood flow restriction). Patient/material and methods: Female CDF1 mice were irradiated on their hind foot using a glue-fixation or tape-fixation method. Glue-fixated mice were only taped during the glueing procedure and had a 10-min unrestricted period afterwards before irradiation, while tape-fixated mice were taped shortly before and throughout irradiation. Mice received single-dose irradiation (19-58 Gy) with either conventional dose rate (CONV, protons 0.06 Gy/s, electrons 0.16 Gy/s) or FLASH (electrons, 223-233 Gy/s). Differences in skin toxicity were analysed.
Results: CONV-treated tape-fixated mice required a 16-17% higher dose to induce skin toxicity relative to glued mice for both protons and electrons. Meanwhile, the fixation method did not affect FLASH-treated mice. The resulting electron FLASH-sparing effect was reduced by 18% due to the shift in radiosensitivity for CONV-treated mice.
Interpretation: CONV-treated tape-fixated mice were more radioresistant than the glue-fixated mice, consistent with the expected response to mild hypoxia. FLASH-treated mice were unaffected. These findings demonstrate the impact of fixation and, in turn, oxygen level on the differential CONV versus FLASH skin response. The results highlight the importance of minimal systemic influence on animals during FLASH studies.
Conflict of interest statement
The authors declare the following financial interests/personal relationships, which may be considered potential competing interests: The study presented in this manuscript was supported by Varian, a Siemens Healthineers Company. BSS and PRP are co-inventors on a patent application (application no. 63257211 and EFS ID 44064136). The remaining authors declare that the research was conducted without commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Kim MM, Verginadis II, Goia D, Haertter A, Shoniyozov K, Zou W, et al. Comparison of FLASH proton entrance and the spread-out Bragg Peak dose regions in the sparing of mouse intestinal crypts and in a pancreatic tumor model. Cancers (Basel). 2021;13:4244. 10.3390/cancers13164244 - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
